World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
95
Citations
80907
World Ranking
9831
National Ranking
5053

Jeff D. Williamson publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Jeff D. Williamson sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 356 publications — 29th percentile

29% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Jeff D. Williamson D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Jeff D. Williamson sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 95 D-Index — 51st percentile

51% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Jeff D. Williamson is affiliated with Wake Forest University in the United States. Their research primarily lies within the field of Medicine, with a particular focus on Cardiology and Cardiovascular Medicine, Psychiatry and Mental Health, Pulmonary and Respiratory Medicine, Public Health, Environmental and Occupational Health, as well as Geriatrics and Gerontology.

Their work covers a wide range of topics, including:

  • Blood Pressure and Hypertension Studies
  • Dementia and Cognitive Impairment Research
  • Cerebrovascular and Carotid Artery Diseases
  • Cardiovascular Health and Disease Prevention
  • Frailty in Older Adults
  • Geriatric Care and Nursing Homes
  • Palliative Care and End-of-Life Issues

Jeff D. Williamson has contributed significantly to several frequent publication venues, including:

  • Alzheimer's & Dementia
  • Innovation in Aging
  • Journal of the American Geriatrics Society
  • The Journals of Gerontology Series A
  • Hypertension

The scientist's notable recent papers include:

  • "Final Report of a Trial of Intensive versus Standard Blood-Pressure Control," 2021, New England Journal of Medicine
  • "Vascular contributions to cognitive impairment and dementia (VCID): A report from the 2018 National Heart, Lung, and Blood Institute and National Institute of Neurological Disorders and Stroke Workshop," 2020, Alzheimer's & Dementia
  • "Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline," 2020, Neurology
  • "Effects of intensive versus standard blood pressure control on domain-specific cognitive function: a substudy of the SPRINT randomised controlled trial," 2020, The Lancet Neurology
  • "Effectiveness of a Nurse-Led Multidisciplinary Intervention vs Usual Care on Advance Care Planning for Vulnerable Older Adults in an Accountable Care Organization," 2021, JAMA Internal Medicine

Collaboration is evident through frequent co-authorship with several researchers including:

  • Nicholas M. Pajewski
  • David M. Reboussin
  • Robyn L. Woods
  • Sarah A. Gaussoin
  • Mark A. Supiano

Best Publications

  • 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

    Paul K. Whelton;Robert M. Carey;Wilbert S. Aronow;Donald E. Casey

  • Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)

    Curt D. Furberg;Jackson T. Wright;Barry R Davis;Jeffrey A. Cutler

  • A Randomized Trial of Intensive versus Standard Blood-Pressure Control

    Jackson T. Wright;Jeff D. Williamson;Paul K. Whelton;Joni K. Snyder

  • Untangling the Concepts of Disability, Frailty, and Comorbidity: Implications for Improved Targeting and Care

    Linda P. Fried;Luigi Ferrucci;Jonathan Darer;Jeff D. Williamson

  • Effect of Structured Physical Activity on Prevention of Major Mobility Disability in Older Adults: The LIFE Study Randomized Clinical Trial

    Marco Pahor;Jack M. Guralnik;Jack M. Guralnik;Walter T. Ambrosius;Steven Blair

  • Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial.

    Jeff D. Williamson;Mark A. Supiano;Mark A. Supiano;William B. Applegate;Dan R. Berlowitz;Dan R. Berlowitz

  • Cognitive decline and dementia in diabetes- : systematic overview of prospective observational studies

    T. Cukierman;H. C. Gerstein;J. D. Williamson

  • 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

    Paul K. Whelton;Robert M. Carey;Wilbert S. Aronow;Donald E. Casey

  • Exercise and dietary weight loss in overweight and obese older adults with knee osteoarthritis: the Arthritis, Diet, and Activity Promotion Trial.

    Stephen P. Messier;Richard F. Loeser;Gary D. Miller;Timothy M. Morgan

  • Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis

    Y. Iturria-Medina;R. C. Sotero;P. J. Toussaint;J. M. Mateos-Pérez

  • Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia: A Randomized Clinical Trial.

    Jeff D. Williamson;Nicholas M. Pajewski;Alexander P. Auchus

  • Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly

    John J. McNeil;Rory Wolfe;Robyn L. Woods;Andrew M. Tonkin

  • Ginkgo biloba for prevention of dementia: a randomized controlled trial.

    Steven T. DeKosky;Steven T. DeKosky;Jeff D. Williamson;Annette L. Fitzpatrick;Richard A. Kronmal

  • Effects of Intensive Diet and Exercise on Knee Joint Loads, Inflammation, and Clinical Outcomes Among Overweight and Obese Adults With Knee Osteoarthritis: The IDEA Randomized Clinical Trial

    Stephen P. Messier;Shannon L. Mihalko;Claudine Legault;Gary D. Miller

  • 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary

    Paul K. Whelton;Robert M. Carey;Wilbert S. Aronow;Donald E. Casey

  • Effect of aspirin on all-cause mortality in the healthy elderly

    John J. McNeil;Mark R. Nelson;Robyn L. Woods;Jessica E. Lockery

  • Depressive symptoms, vascular disease, and mild cognitive impairment: findings from the Cardiovascular Health Study.

    Deborah E. Barnes;George S. Alexopoulos;Oscar L. Lopez;Jeff D. Williamson

  • Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): A randomised open-label substudy

    Lenore J. Launer;Michael E. Miller;Jeff D. Williamson;Ron M. Lazar

  • Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: a meta-analysis of randomised controlled trials

    Marco Pahor;Bruce M Psaty;Michael H Alderman;William B Applegate

  • Relationship Between Baseline Glycemic Control and Cognitive Function in Individuals With Type 2 Diabetes and Other Cardiovascular Risk Factors: The Action to Control Cardiovascular Risk in Diabetes-Memory in Diabetes (ACCORD-MIND) trial

    Tali Cukierman-Yaffe;Tali Cukierman-Yaffe;Hertzel C Gerstein;Jeff D. Williamson;Ronald M Lazar

Frequent Co-Authors

Lenore J. Launer
Lenore J. Launer National Institutes of Health
Stephen B. Kritchevsky
Stephen B. Kritchevsky Wake Forest University
Steven T. DeKosky
Steven T. DeKosky University of Florida
Oscar L. Lopez
Oscar L. Lopez University of Pittsburgh
Mark A. Espeland
Mark A. Espeland Wake Forest University
Marco Pahor
Marco Pahor University of Florida
Barry I. Freedman
Barry I. Freedman Wake Forest University
Karen L. Margolis
Karen L. Margolis HealthPartners
Jack M. Guralnik
Jack M. Guralnik University of Maryland, Baltimore
Donald W. Bowden
Donald W. Bowden Wake Forest University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Medicine opens the door to various healthcare careers. For those looking for flexible education options or alternative career tracks, several online programs are available. These programs can help you gain the skills you need, often with a more convenient learning experience.

Nursing is a popular pathway, and some lpn to rn programs without teas test make it easier for Licensed Practical Nurses to advance their qualifications without the need for additional entrance exams.

If you are interested in healthcare leadership roles rather than clinical practice, you might consider the best online healthcare administration degree options. These programs prepare students for management positions within hospitals, clinics, and other care facilities.

Registered Nurses aiming to become Nurse Practitioners can explore adn to np programs online, which offer an accelerated path from an Associate Degree in Nursing to a Master of Science in Nursing.

For those fascinated by food, health, and wellness, several accredited online nutrition degrees are available. These programs can lead to careers in clinical nutrition, dietetics, or health education.

Best Scientists Citing Jeff D. Williamson

Trending Scientists

Recently Published Articles